Analytical Characterization, Pharmacokinetics, Safety, and Preliminary Immunogenicity of GNR-062, an Agalsidase Beta Biosimilar Candidate, in Healthy Male Volunteers.
Lyagoskin I, Smolov M, Markova O, Klyashtorny V, Pantyushenko M, Koroleva M, Strizhakova O, Shukurov R, Khamitov R
The online reader was unable to display this document directly. This may occur if the repository host is temporarily unreachable, or if security restrictions (CORS) prevent embedded viewing.